Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression

Journal of the American College of Cardiology

Volumn 39, Issue 2, 2002, Pages 351-358

  Bauersachs, Johann ^a   Heck, Marina ^b   Fraccarollo, Daniela ^a   Hildemann, Steven K ^c   Ertl, Georg ^a   Wehling, Martin ^b   Christ, Michael ^b,d  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^c Pharmacia GmbH   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACEBO; SPIRONOLACTONE; TRANDOLAPRIL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HEART VENTRICLE REMODELING; HEMODYNAMIC MONITORING; MALE; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME; VASCULAR RING; VASODILATATION;

ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; INDOLES; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; SPIRONOLACTONE; SUPEROXIDES; VASODILATION; VENTRICULAR REMODELING;

EID: 0037116558     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01729-6     Document Type: Article

References (36)

1. NO: The primary EDRF
2. Endothelial dysfunction: A novel therapeutic target - Endothelial dysfunction in human disease
3. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure
4. Endothelium-dependent vasodilation is attenuated in patients with heart failure
5. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure
6. Endothelial function in chronic congestive heart failure
7. Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat hearts
8. Oxygen free radicals and congestive heart failure
9. Increased oxidative stress in patients with congestive heart failure
10. Endothelial dysfunction coincides with an enhanced NO synthase expression and superoxide anion production
11. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylyl cyclase expression: Role of enhanced vascular superoxide production
12. Endothelium as a therapeutic target in heart failure
13. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure
14. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure
15. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
16. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
17. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
18. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure
19. Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE-inhibition: Mechanistic evidence to support RALES
20. Chronic endothelin receptor blockade attenuates progressive ventricular dilatation and improves cardiac function in rats with myocardial infarction: Possible involvement of myocardial endothelin system in ventricular remodeling
21. Vasodilator dysfunction in aged spontaneously hypertensive rats: Changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production
22. Endothelin receptor blockade improves endothelial vasomotor dysfunction in heart failure
23. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production
24. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure
25. Peripheral artery structure and endothelial function in heart failure
26. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure
27. Aorta and skeletal muscle NO synthase expression in experimental heart failure
28. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure
29. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
30. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
31. Survival after myocardial infarction in the rat: Role of tissue angiotensin-converting enzyme inhibition
32. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt
33. Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats
34. Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet
35. Three new epoxy-spirolactone derivatives: Characterization in vivo and in vitro
36. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium